Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Detoxification of carcinogenic aromatic and heterocyclic amines by enzymatic reduction of the N-hydroxy derivative
1999
King, R.S.; Teitel, C.H.; Shaddock, J.G.; Casciano, D.A.; Kadlubar, F.F.
Cancer Lett.
143
167-171
Isolation and purification of two human liver UDP-glucuronosyltransferases
1987
Irshaid, Y.M.; Tephly, T.R.
Mol. Pharmacol.
31
27-34
4-Aminobiphenyl N-glucuronidation by liver microsomes: optimization of the reaction conditions and characterization of the UDP-glucuronosyltransferase isoforms
2006
Al-Zoughool, M.; Talaska, G.
J. Appl. Toxicol.
26
524-532
NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity
2006
Zhang, N.; Liu, L.; Liu, F.; Wagner, C.R.; Hanna, P.E.; Walters, K.J.
J. Mol. Biol.
363
188-200
Identification and characterization of functional rat arylamine N-acetyltransferase 3: comparisons with rat arylamine N-acetyltransferases 1 and 2
2006
Walraven, J.M.; Doll, M.A.; Hein, D.W.
J. Pharmacol. Exp. Ther.
319
369-375
N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice
2006
Loehle, J.A.; Cornish, V.; Wakefield, L.; Doll, M.A.; Neale, J.R.; Zang, Y.; Sim, E.; Hein, D.W.
J. Pharmacol. Exp. Ther.
319
724-728
Cigarette smoke toxicants as substrates and inhibitors for human cytosolic SULTs
2007
Yasuda, S.; Idell, S.; Fu, J.; Carter, G.; Snow, R.; Liu, M.C.
Toxicol. Appl. Pharmacol.
221
13-20
Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2
2007
Liu, L.; Von Vett, A.; Zhang, N.; Walters, K.J.; Wagner, C.R.; Hanna, P.E.
Chem. Res. Toxicol.
20
1300-1308
Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica
2008
Martins, M.; Pluvinage, B.; de la Sierra-Gallay, I.L.; Barbault, F.; Dairou, J.; Dupret, J.M.; Rodrigues-Lima, F.
J. Mol. Biol.
383
549-560
Mutation analysis in UGT1A9 suggests a relationship between substrate and catalytic residues in UDP-glucuronosyltransferases
2008
Patana, A.; Kurkela, M.; Finel, M.; Goldman, A.
Protein Eng. Des. Sel.
21
537-543
close all tables 
open all tables
top
